A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
Clinical trial NCT01232569 · COMPLETED
Trial details
- NCT number
- NCT01232569
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-05-01
- Enrollment
- 656
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.